This message was sent to ##Email##
| ACS CANCER PROGRAMS UPDATES|
The Commission on Cancer’s new accreditation standards, Optimal Resources for Cancer Care (2020 Standards), are now available for free download from the Commission on Cancer (CoC) website.
|Register now for free 2020 CoC Standards webinar
In a video posted to the American College of Surgeons Cancer Programs’ web page, CoC Chair Lawrence Shulman, MD, FACP, FASCO, discussed the impetus and process for developing the new standards.
“A year and a half ago, we decided to do a full-scale revision of the standards that we use to accredit hospital cancer programs throughout the U.S.,” said Dr. Shulman. “We thought this was needed because medicine, and specifically oncology, was changing at a rapid rate, and we needed to reassess the standards that we use to measure programs’ performance.”
The CoC is planning multiple educational programs on the 2020 CoC Standards. Registration is now open for a 40-minute free standards overview webinar at 1:00 pm CT on November 18, 2019. Watch The Brief and visit the CoC website for more information on the events outlined here, along with additional offerings.
- Three in-person workshops will cover the 2020 standards and the changes to the National Cancer Database (NCDB):
- CoC 2020: A Glimpse into the Future, Rosemont IL, November 21–22, 2019. A limited number of spaces have become available for this session. These are available on a first come, first served basis until the spaces are filled. Contact Andrea Scrementi at firstname.lastname@example.org by November 4 to confirm available space and to register.
- CoC 2020: A Glimpse into the Future, Rosemont IL, April 22–23, 2020 (registration opens December 2019)
- CoC 2020: A Glimpse into the Future, Denver, CO, August 28–29, 2020
- Workshop recordings will be available for purchase through the online learning management system (January 2020)
- Free Overview of CoC 2020 Standards webinar, November 18, 2019
- A free online series of short webinars will include tips for each standard (early 2020)
- CAnswer Forum Live 2020 will include a series of six webinars addressing the 2020 CoC Standards as well as other program areas (premiering February 2020)
- Monthly highlights will be featured in The Brief
- Presentations are scheduled at meetings and conferences of CoC member organizations (watch for additions to this schedule):
- Association of Cancer Executives (ACE), January 2020
- National Cancer Registrars Association (NCRA), May 2020
|| SPONSORED CONTENT||Advertisement
The Commission on Cancer (CoC) welcomed the following new members and new leaders at their annual meeting held on Sunday, October 27 in San Francisco in conjunction with the American College of Surgeons (ACS) Clinical Congress.
|CoC recognizes new and outgoing members
New members representing the ACS Fellowship and serving a three-year term:
Maria Castaldi, MD, FACS
Michael Gynn, MD, FACS
David Luyimbazi, MD, FACS
Sangeetha Prabhakaran, MD, FACS
Christina Stevenson, MD, FACS
New members representing CoC member organizations for a three-year term:
Ana Berlin, MD, MPH, FACS, American Academy of Hospice and Palliative Medicine
David Foley, MD, FAAP, FACS, American Academy of Pediatrics
Julie Silver, MD, American Academy of Physical Medicine and Rehabilitation
Arnold Baskies, MD, FACS, American Cancer Society
Ana Maria Lopez, MD, FACS, American College of Physicians
Carmen Solorzano, MD, FACS, American College of Surgeons Board of Governors
John Mullinax, MD, FACS, American College of Surgeons Young Fellows Association
Elin Sigurdson, MD, FACS, American Radium Society
Frederick Schnell, MD, FACP, Community Oncology Alliance
Cheryl Sheridan, CTR, RHIT, National Cancer Registrars Association
Summer Dewdney, MD, Society of Gynecologic Oncology
Linda Martin, MD, MPH, FACS, Society of Thoracic Surgeons
New leaders include:
Timothy Mullett, MD, FACS, CoC Chair-Elect
Daniel Boffa, MD, FACS, CoC Quality Integration Committee Chair
Sharon Lum, MD, FACS, CoC Quality Integration Committee Vice-Chair
Arnold Baskies, MD, FACS, CoC Advocacy Committee Chair
Jennifer Rosen, MD, FACS, CoC Advocacy Committee Vice-Chair
Quyen Chu, MD, FACS, CoC Cancer Liaison Program Vice-Chair
The Commission on Cancer would like to thank the following members and leaders who have completed their terms and recognize all their contributions in developing and supporting the initiatives of the CoC.
Representing the Fellowship:
Karl Bilimoria, MD, FACS
William Dooley, MD, FACS
Hisakazu Hoshi, MD, FACS
Brad Waddell, MD, FACS
Sandra Wong, MD, FACS
Stephen Yang, MD, FACS
Representing Member Organizations:
Bridget Fahy, MD, FACS, American Academy of Hospice & Palliative Medicine
Maria Velez, MD, FAAP, American Academy of Pediatrics
Eric Wisotzky, MD, American Academy of Physical Medicine & Rehabilitation
Lee Hartner, MD, American College of Physicians
Helen Pass, MD, FACS, American College of Surgeons Board of Governors
Heidi Overton, MD, American College of Surgeons Resident and Associate Society
Joshua Mammen, MD, PhD, FACS, American College of Surgeons Young Fellows Association
Robert “Bo” Gamble, MD, Community Oncology Alliance
Ann Griffin, PhD, CTR, National Cancer Registrars Association
Edward Grendys, Jr., MD, FACS, Society of Gynecologic Oncology
Matthew Facktor, MD, FACS, CoC Quality Integration Committee Chair
Daniel Boffa, MD, FACS, CoC Quality Integration Vice-Chair
Alan Thorson, MD, FACS, CoC Advocacy Committee Chair
Leslie Kohman, MD, FACS, CoC Advocacy Committee Vice-Chair
Timothy Mullett, MD, FACS, CoC Cancer Liaison Program Vice-Chair
|| SERVICE SHOWCASE||Advertisement
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
The CoC recognized three State Chairs for outstanding performance in 2018: Maria Castaldi, MD, FACS, Manhattan Council State Chair; Susan Lee, MD, FACS, Brooklyn-Long Island State Chair; and Ingrid Lizarraga, MD, FACS, Iowa State Chair.
|CoC honors three State Chairs for outstanding performance
The State Chair Outstanding Performance Award recognizes individuals who exhibit outstanding leadership and innovation, and who make significant contributions to the improvement of cancer in his or her state or region. As State Chairs, they are responsible for ongoing communication with the Cancer Liaison Physicians in their state, support for CoC initiatives and activities, and collaboration with partners such as the ACS Chapter, American Cancer Society and Comprehensive Cancer Control Coalition.
The American College of Surgeons Cancer Programs has two exciting career opportunities for Certified Tumor Registrars (CTR) or CTR-eligible professionals with the National Cancer Database (NCDB) and the American Joint Committee on Cancer (AJCC).
|ACS Cancer Programs offer career opportunities for CTRs
The NCDB, known for collecting data that represent more than 72 percent of newly diagnosed cancer cases nationwide and more than 40 million submitted records, provides tools and resources to help 1,500 CoC-accredited programs improve delivery and quality of care for cancer patients.
The AJCC provides worldwide leadership in the development of evidence-based systems for the classification and management of cancer in collaboration with multidisciplinary organizations dedicated to cancer surveillance and to improving care. This position will join the team working with physician experts around the world in developing the AJCC 9th edition, as well as providing education for, and answering questions from, fellow registrars.
For details, please visit the American College of Surgeons website for careers at ACS.
Registration is now open for the next CAnswer Forum Live webinar from 12:00 noon to 1:00 pm CST on December 11. Please submit your questions by 5:00 pm CST on Friday, November 22.
|Submit your questions for December 11 CAnswer Forum Live
If you missed the September 25 CAnswer Forum Live webinar, the session recording and slides are available on the CAnswer Forum LIVE web page.
The American Joint Committee on Cancer (AJCC) is seeking volunteers from across the oncology community to assist with updates to its Cancer Staging System.
|AJCC seeks volunteers to assist with Cancer Staging System updates
The process will include rigorous vetting of the latest information from scientific research and peer-reviewed publications to support changes to the Cancer Staging System and maintain the standard of excellence that the AJCC has established. The AJCC is seeking broad participation from across the disciplines and specialties in oncology to participate in the AJCC’s Expert Panels, the disease-focused groups that collaboratively contribute to authorship of the Cancer Staging System.
Those interested in participating in the update process should complete the online survey by November 18, 2019:
Applications will be reviewed by the AJCC Editorial Committee and Exert Panel Chairs and Leadership.
|| PRODUCT SHOWCASE||Advertisement
The VTI TQI Doppler system, with its disposable probes, provides a reliable solution for transcutaneous and invasive assessment of vasculature during surgery. In reconstructive applications, the TQI system allows for perioperative localization of perforators, assessment of pedicle anastamosis, as well as assessment of flap viability.
The National Accreditation Program for Breast Centers’ (NAPBC) Board of Directors recently agreed to modify requirements to the 2018 NAPBC Standards Manual (2018 edition) for two standards: Standard 1.2: Multidisciplinary Breast Care Conference and Standard 6.1: Quality and Outcomes. These changes will go into effect on January 1, 2020.
|NAPBC modifies some standards for 2020
The NAPBC Clarifications, Reminders and FAQ document released in May 2019 has been updated to reflect these changes. It may be downloaded from the NAPBC website
and the resources section of the NAPBC portal. October 2019 additions/updates are designated in the document.
If you have any questions regarding the interpretation of NAPBC standards, please be sure to post your question to the NAPBC section of the CAnswer Forum.
The National Accreditation Program for Rectal Cancer (NAPRC) is seeking physicians to join its accreditation surveyor team. Surveyors conduct on-site visits with rectal cancer programs seeking NAPRC accreditation to assist in verifying a program’s compliance with the NAPRC Standards.
|The NAPRC surveyor team needs YOU!
Applicants must be actively practicing physicians specializing in rectal cancer care and working in a program that is NAPRC accredited or is actively working toward NAPRC accreditation. Please visit the NAPRC website for more information on qualifications and to download the application by November 11.
| HEALTH CARE NEWS AND UPDATES|
The New York Times
Just as computers can predict your shopping habits, researchers are using them to map the medical history of cancer patients to predict and treat the disease, and possibly to prevent it.
Veterans saw a spike in urinary, prostate, liver and blood cancers during nearly two decades of war, and some military families now question whether their exposure to toxic environments is to blame, according to a McClatchy investigation.
Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice.
These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick up signs that cancer is preparing to spread, before cancer cells arrive.
Breast cancer patients who endured Hurricane Katrina in 2005 have a 15% higher mortality rate than those patients not exposed to the storm, according to a University of Michigan researcher.
This increase was likely caused by disaster-related health care disruptions, said Sue Anne Bell, an assistant professor at the U-M School of Nursing and a member of the U-M Institute for Healthcare Policy and Innovation.
Cancer cells can spread to distant locations of the body by degrading their surrounding scaffold, which is known as the extracellular matrix (ECM). Now, researchers at the Francis Crick Institute have identified a key mechanism that controls this process and that they believe could inspire the development of new drugs to stop cancer metastasis.
| IMPORTANT DATES AND DEADLINES|
| || |
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the American College of Surgeons Cancer Programs from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The American College of Surgeons and Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063